Under this method, P values are subject to adjustments to reflect the actual number of adjudicated events. When the database for the second interim efficacy and safety analysis was locked. The number of adjudicated primary and major adverse cardiovascular events was approximately 76% of the 1612 events targeted for completion of the study.